Edition:
United Kingdom

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

791.95INR
15 Dec 2017
Change (% chg)

Rs10.50 (+1.34%)
Prev Close
Rs781.45
Open
Rs788.00
Day's High
Rs794.80
Day's Low
Rs786.10
Volume
221,302
Avg. Vol
537,468
52-wk High
Rs1,274.70
52-wk Low
Rs752.30

Chart for

About

Strides Shasun Limited, formerly Strides Arcolab Limited, is a vertically integrated global pharmaceutical company. The Company is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, as well as biotech. Its business segments include Pharmaceutical and Biotech businesses. Its... (more)

Overall

Beta: 0.59
Market Cap(Mil.): Rs74,972.77
Shares Outstanding(Mil.): 89.49
Dividend: 4.50
Yield (%): 0.54

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed

* SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED Source text - http://bit.ly/2kkCPEo Further company coverage:

04 Dec 2017

BRIEF-Strides Shasun gets U.S. FDA approval for acetazolamide tablets​

* Says product to be marketed by Strides Pharma Inc in the US market‍​ Source text for Eikon: Further company coverage:

22 Nov 2017

BRIEF-Strides Shasun approves scheme of amalgamation for merger of units with co‍​

* Says approved scheme of amalgamation for merger of units Arrow Remedies, Fagris Medica, Strides Chemicals with co‍​ Source text - http://bit.ly/2A2odNz Further company coverage:

31 Oct 2017

BRIEF-India's Strides Shasun Sept-qtr consol profit down 87 pct

* Sept quarter consol net profit 107.3 million rupees versus profit of 854.3 million rupees last year

31 Oct 2017

BRIEF-Strides Shasun gets U.S. FDA approval for omega-3-acid ethyl esters capsules

* Says Strides Shasun receives USFDA approval for omega-3-acid ethyl esters capsules

20 Sep 2017

BRIEF-Strides Shasun gets shareholders' nod for appointment of Shashank Sinha as MD

* Gets shareholders' nod for appointment of Shashank Sinha as MD Source text: http://bit.ly/2x75CQP Further company coverage:

15 Sep 2017

BRIEF-India's Strides Shasun gets U.S. FDA nod for potassium citrate extended-release tablets

* Says receives USFDA approval for potassium citrate extended-release tablets

12 Sep 2017

BRIEF-Strides Shasun seeks shareholders' nod for appointment of Shashank Sinha as MD

* Seeks shareholders' nod for appointment of Shashank Sinha as MD Source text - http://bit.ly/2v8XIHt Further company coverage:

24 Aug 2017

BRIEF-India's Strides Shasun June-qtr consol profit falls

* June quarter consol profit 57.8 million rupees versus 324.7 million rupees last year

11 Aug 2017

BRIEF-Strides Shasun gets USFDA approval for cetirizine softgel capsules

* Says receives USFDA approval for cetirizine softgel capsules

24 Jul 2017

Earnings vs. Estimates